Skip to main content

Table 2 Choice of pharmacotherapy by group

From: An individually-tailored smoking cessation intervention for rural Veterans: a pilot randomized trial

Medicationa Quitline Referral Tailored interventionb Total
n (%) n (%) n (%)
Any use of productc
 Nicotine patch 18 (56.3) 12 (38.7) 30 (47.6)
 Nicotine gum 10 (31.3) 7 (22.6) 17 (27.0)
 Nicotine lozenge 9 (28.1) 9 (29.0) 18 (28.6)
 Bupropion 8 (25.0) 5 (16.1) 13 (20.6)
 Varenicline 10 (31.3) 13 (41.9) 23 (36.5)
Monotherapy
 Nicotine replacement therapy 6 (18.8) 2 (6.5) 8 (12.7)
  Nicotine patch 2 (6.3) 0 (0.0) 2 (3.2)
  Nicotine gum 3 (9.4) 0 (0.0) 3 (4.8)
  Nicotine lozenge 1 (3.1) 2 (6.5) 3 (4.8)
 Bupropion 1 (3.1) 1 (3.2) 2 (3.2)
 Varenicline 10 (31.3) 13 (41.9) 23 (36.5)
Combination therapy
 Any combination NRT 12 (37.5) 11 (35.5) 23 (36.5)
  Nicotine patch + nicotine gum 5 (15.6) 5 (16.1) 10 (15.9)
  Nicotine patch + nicotine lozenge 7 (21.9) 6 (19.4) 13 (20.6)
 Any bupropion + NRT combination 7 (21.9) 4 (12.9) 11 (17.5)
  Nicotine patch + bupropion 4 (12.5) 1 (3.2) 5 (7.9)
  Nicotine gum + bupropion 2 (6.3) 2 (6.5) 4 (6.3)
  Nicotine lozenge + bupropion 1 (3.1) 1 (3.2) 2 (3.2)
  1. aParticipants were allowed to switch their medication choice one time due to perceived lack of efficacy or side effects. A total of six participants switched medications, including two participants in the Tailored intervention condition and four in the Quitline Referral condition. For those who switched medications, both choices are represented in the table
  2. bTwo participants in the tailored intervention condition dropped out of the intervention prior to choosing study medication
  3. cAs monotherapy or in combination with another medication